UPDATE : Monday, September 7, 2020
상단여백
New coronavirus affect related stocks in different ways
Amid mounting fears of the new coronavirus infection, share prices of relat...
by Jeong Sae-im  |  2020-01-30 17:36
라인
Celltrion tops list of pharmaceutical brand reputation in January
Celltrion took the top place in the domestic brand reputation list of pharm...
by Jeong Sae-im  |  2020-01-30 16:10
라인
Merck Korea worker commits suicide
After Merck Biopharma Korea shut down the general medicine (GM) division la...
by Kim Yun-mi  |  2020-01-30 16:09
라인
Astellas’ rheumatoid arthritis drug Smyraf wins regulatory nod
Astellas Pharma’s Smyraf (ingredient: peficitinib) obtained regulatory appr...
by Kim Yun-mi  |  2020-01-30 14:07
라인
Hanmi targets revenue of ₩100 billion from Rosuzet sales
Hanmi Pharmaceutical said it aims to earn 100 billion won ($85 million) fro...
by Shim Hyun-tai  |  2020-01-29 18:05
라인
Drugmaker cancels event for 1,000 doctors due to new coronavirus risk
The outbreak of China’s novel coronavirus is affecting not only the medical...
by Park Gi-taek  |  2020-01-29 15:51
라인
‘Dupixent revolutionary atopic dermatitis drug to end lack of fundamental treatment’
Sanofi's Dupixent (ingredient: dupilumab), the only biologic drug for a...
by Kim Yun-mi  |  2020-01-29 14:00
라인
Afstyla wins nod as new therapy for hemophilia A
Afstyla, a new preventive treatment for hemophilia A developed in Korea, ha...
by Kim Yun-mi  |  2020-01-24 08:18
라인
MIT promotes industrial liaison program to Korean drugmakers
“In Boston, corporations are making successful cases through collaboration ...
by Jeong Sae-im  |  2020-01-23 12:04
라인
'Reimbursement for Repatha to expand treatment options for ASCVD patients'
Amgen is set to expand treatment options for atherosclerotic cardiovascular...
by Lee Han-soo  |  2020-01-22 15:14
라인
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019
The domestic sales of sodium-glucose transport protein-2 (SGLT-2) inhibitor...
by Kim Yun-mi  |  2020-01-22 15:10
라인
HanAll remains positive of eye treatment’s efficacy despite initial failure
HanAll Biopharma said that it has failed to meet the primary endpoint for i...
by Lee Han-soo  |  2020-01-21 15:12
라인
SK Biopharma’s US partner gets EMA nod for sleepiness treatment
Jazz Pharmaceuticals, SK Biopharmaceutical’s U.S. partner, has received sal...
by Lee Han-soo  |  2020-01-21 14:22
라인
Some Merck Korea workers commute from provinces to Seoul every day
Merck Biopharma Korea completed the closure of the general medicine (GM) di...
by Kim Yun-mi  |  2020-01-21 14:21
라인
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months
Daewoong Pharmaceutical said the U.S. sales of its botulinum toxin Nabota (...
by Jeong Sae-im  |  2020-01-21 11:43
라인
CoImmune acquires Formula Pharmaceuticals
CoImmune, a joint venture set up by SCM Life Science and Genexine in the U....
by Lee Han-soo  |  2020-01-20 15:45
라인
Pfizer’s spinoff of generics unit causes disputes with trade union
Pfizer’s spinoff of its generics business division has made the employment ...
by Kim Yun-mi  |  2020-01-20 15:44
라인
Korea’s botulinum toxin exports hit record high in 2019
Exports of botulinum toxin products recorded the largest volume last year i...
by Jeong Sae-im  |  2020-01-20 11:38
라인
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease
People with ulcerative colitis and Crohn’s disease who have failed with sta...
by Kim Yun-mi  |  2020-01-17 17:30
라인
GenScript to market Genopis' GMP-grade plasmid DNA
Genopis, a U.S offshoot of Helixmith, said that it has entered into a strat...
by Lee Han-soo  |  2020-01-17 17:28
여백
여백
여백
Back to Top